Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Respirology ; 22(7): 1423-1429, 2017 10.
Artigo em Inglês | MEDLINE | ID: mdl-28556405

RESUMO

BACKGROUND AND OBJECTIVE: Tuberculosis (TB) remains a major public health challenge. China accounts for more than 10% of the global TB burden, and effective modelling of TB trends remains limited. METHODS: We used data drawn primarily from two Chinese nation-wide cross-sectional epidemiological surveys combined with data from China's National Disease Reporting Network to construct an eight-state Markov model that simulates TB prevalence. By adjusting the relevant parameters, we evaluated which characteristics have the greatest bearing upon prevalence and efficacy of the response measures. RESULTS: If current trends continue, the prevalence of TB in China will enter an 8-year period of decline from approximately 390 to 200 cases per 100 000 population and stabilize at 163 cases per 100 000 population, which is a figure well above the World Health Organization (WHO) goal of eliminating TB by 2050. We find that the proportion of notified cases in the population, the rate of progression from latent to active and the overall treatment success rate are the chief factors affecting disease progression. CONCLUSION: We suggest a 90-90-90 strategy, wherein the proportion of notified cases in the population reaches 90%, the risk of progression from latent to active is decreased by 90% compared with the current level and the overall treatment success rate is increased to 90%. This strategy could reduce TB prevalence to less than 10 cases per 100 000 population within 5 years and to 1.77 cases per 100 000 population within 50 years.


Assuntos
Antituberculosos/uso terapêutico , Objetivos , Tuberculose Latente/epidemiologia , Saúde Pública , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia , Organização Mundial da Saúde , China , Estudos Transversais , Humanos , Tuberculose Latente/prevenção & controle , Estudos Longitudinais , Cadeias de Markov , Prevalência , Risco , Tuberculose Resistente a Múltiplos Medicamentos/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA